JUN 24, 2019 2:36 PM PDT

Drug Combination May Combat Deadly Drug-Resistant Fungus

WRITTEN BY: Nouran Amin

A drug combination of anti-fungal and anti-bacterial medications may be effective against the spread of a highly infectious and deadly fungus--Candida auris (C. auris). According to the Centers for Disease and Control, C. auris was first discovered in Japan and has affected individuals in more than 20 countries and sickened 643 Americans in 11 U.S. states. The fungus has baffled health officials as the search for treatment options are higher than ever.

"Few treatment options are available for patients infected with Candida auris, which causes invasive, life-threatening infections, usually in patients who are already critically ill or have compromised immune systems," said Brennan-Krohn, MD, a post-doctoral research fellow in the lab of James E. Kirby, MD, Director of the Clinical Microbiology Laboratory at BIDMC. "It has an alarming propensity to spread from patient to patient and survive on surfaces in rooms, resulting in hospital outbreaks."

Findings presented at the annual meeting of the American Society for Microbiology discuss how the search for new treatment approaches allowed researchers to use a modified inkjet printer. The modified inkjet printer allows for rapid and uniform antimicrobial screening for the testing of antifungal drugs, amphotericin and caspofungin, in combination with two antibacterial antibiotics antibiotics, minocycline and rifampin,—to maximize the efficacy against fungal infections. Results showed three new combinations of antifungal and antibacterial drugs that demonstrated effectiveness against C. auris.

Although the dugs have not been tested in combination in C. auris-infected humans, the drugs are actually FDA-approved and presently prescribed for patients with a variety of infections.

However, if the drugs prove to eradicate C. auris infections in clinical studies, then physicians already have access to the effective treatment for their patients infected with C. auris.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 11, 2020
Cardiology
APR 11, 2020
Cell Transplant Repairs Brain After Stroke
Using cell therapy, researchers from Lund University in Sweden have successfully restored mobility and a sense of touch ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 11, 2020
Drug Discovery & Development
APR 11, 2020
Promising Experimental Anti-Malarial Drug
At St. Jude Children’s Research Hospital, researchers discovered a fast-acting anti-malarial compound with promisi ...
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
Researchers Use AI to Accelerate COVID-19 Drug Development
Researchers from the National University of Singapore (NUS) have developed an artificial intelligence platform to accele ...
MAY 23, 2020
Cancer
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Potential Targets for Alcohol Induced Liver Disease
Alcohol-related liver disease (ALD) is a fatal condition targeting more than 150 million people. Part of what makes it d ...
Loading Comments...